Review

Full ReviewReview byQuestions this resource addresses
Click here for full reviewRichard LessellsDoes adjunctive corticosteroid therapy in conjunction with antituberculous chemotherapy reduce the risk of disability or death in adults with tuberculous meningitis? . . .

Bookmark this page

Email this page to a friend

Print this page

Resource Details

Doc TitleDexamethasone for the treatment of tuberculous meningitis in adolescents and adults
LinkClick here for the original resource http://...
Author(s)Guy E. Thwaites et al
Abstract545 patients over 14years old from two centres in Vietnam randomly allocated to dexamethasone or placebo in conjunction with standard quadruple antituberculous chemotherapy for TB meningitis.
No significant difference between groups in primary outcome (death or severe disability at 9 months)
Significantly reduced mortality in dexamethasone group (most marked in those with mild disease at entry)
Only significant secondary outcome was reduced time to fever clearance in steroid group
Mortality significantly higher amongst HIV-infected adults but no significant benefit from dexamethasone treatment
Significantly fewer adverse drug reactions to antituberculous therapy in dexamethasone group
PublisherNew England Journal of Medicine
SourceNew England Journal of Medicine
Publication TypeCare guideline, Journal article
CategoryTreatment
Level of EvidenceRCT
CoverageNational
FormatHtml
LanguageEnglish
Access RightsNeLH Core Content
Date of publishing10/21/2004
Date of posting04/17/2005
Date of last review by us04/17/2005